DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the KRONOX LAB SCIENCES LTD (KRONOX) share price today?

KRONOX LAB SCIENCES LTD (KRONOX) is trading at ₹151.94 on the NSE, up 0.99% on the day. Source: DocStoX.

What is the PE ratio of KRONOX LAB SCIENCES LTD?

KRONOX LAB SCIENCES LTD has a price-to-earnings (PE) ratio of 22.1 in the Chemicals sector.

What is the market capitalisation of KRONOX LAB SCIENCES LTD?

KRONOX LAB SCIENCES LTD has a market capitalisation of approximately ₹571 crore.

KRONOX LAB SCIENCES LTD

KRONOX·NSE·Chemicals

₹151.94▲ +1.49 (+0.99%)

Chemicals · Specialty Chemicals

Debt-free and consistently profitable

Day₹147.22

₹152.51

52W₹96

₹19457%

Open

₹150.00

High

₹152.51

Low

₹147.22

Prev Close

₹150.45

Volume

1.21L

VWAP

₹149.84

Snapshot

Key fundamentals

Market Cap

₹571 Cr

P/E Ratio

22.15Fair

P/B Ratio

4.78

EPS

₹6.86

Book Value

₹31.30

ROE

28.26%Strong

ROCE

44.00%Efficient

Dividend Yield

0.33%

Debt / Equity

0.02Low

Face Value

₹10.00

52W High

₹194.00

52W Low

₹96.00

Sector

Chemicals

Industry

Specialty Chemicals

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹63

▼ 58.5%downside

Trading at ₹152 — 58% above our estimate

BearFair valueBull

₹54₹63₹73

/100

Business quality — Solid

Growth 1Profitability 100Efficiency 58Valuation 84

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet
Revenue has been shrinking

Strengths

Virtually debt-free balance sheet
Strong returns on equity (28%)
Capital is working hard (ROCE 44%)
Promoters hold a controlling stake

Risks

Revenue has been shrinking

How we got there

Fair value methods

Residual income

28% ROE fading to 13% over ~10 yrs, on ₹31 book

₹60

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹70

Analyst target

No analyst coverage

—

Blended fair value₹63

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (28%)
Capital is working hard (ROCE 44%)
Promoters hold a controlling stake

Bear case

Revenue has been shrinking

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

22.1Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

28.3%Strong

Above 15% is considered healthy for Indian equities

ROCE

44.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.02Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹571 Cr

P/B

4.78

EPS

₹6.86

Div Yield

0.33%

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Reasonable

P/E 22.1×

Growth

Slow

+2% rev CAGR

Profitability

Excellent

28.3% ROE

Financial health

Rock solid

D/E 0.02

Momentum

N/A

No technicals

Today

Trading activity

Delivery %41.5%

Turnover₹181.57L Cr

Trades2,127

VWAP₹149.84

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+1.8%

+10.3%

10Y

—

Profit

+20.0%

+22.6%

10Y

—

EPS

—

10Y

—

Profile

Pros

Company is almost debt free.
Company has delivered good profit growth of 23.3% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
Company's working capital requirements have reduced from 128 days to 71.2 days

Watch-outs

Cons

The company has delivered a poor sales growth of 10.1% over past five years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

74%

Promoter

Promoters

74.2%0.00

Public

23.7%+0.02

FII / FPI

0.0%-0.04

DII

2.1%+0.02

Total shareholders

32,479-990 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter74.21%

FII0.04%

DII2.07%

Public23.68%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]